NLRP3 and Salla disease: Fluoxetine can prevent the activation of NLRP3 inflammasome and avoiding SD-induced neurotoxicity. Furthermore, the activation of STAT3 is an important target that regulated the expression of NLRP3 inflammasomes in an SD model.